Cargando…

Long-term survival and late complications of intensity-modulated radiotherapy for recurrent nasopharyngeal carcinoma

BACKGROUND: To evaluate the effectiveness and toxicities of intensity-modulated radiotherapy (IMRT) for locally recurrent nasopharyngeal carcinoma (NPC). METHODS: One hundred and eighty-four previously irradiated NPC patients with recurrent disease and re-irradiated by IMRT between February 2005 to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kong, Fangfang, Zhou, Junjun, Du, Chengrun, He, Xiayun, Kong, Lin, Hu, Chaosu, Ying, Hongmei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6245884/ https://www.ncbi.nlm.nih.gov/pubmed/30453915 http://dx.doi.org/10.1186/s12885-018-5055-5

Ejemplares similares

Pre-treatment Serum Lactate Dehydrogenase is Predictive of Survival in Patients with Nasopharyngeal Carcinoma Undergoing Intensity-Modulated Radiotherapy
por: Oei, Ronald Wihal, et al.
Publicado: (2018)

Patterns of local-regional failure after primary intensity modulated radiotherapy for nasopharyngeal carcinoma
por: Kong, Fangfang, et al.
Publicado: (2014)

Progression-Free Survival Prediction in Patients with Nasopharyngeal Carcinoma after Intensity-Modulated Radiotherapy: Machine Learning vs. Traditional Statistics
por: Oei, Ronald Wihal, et al.
Publicado: (2021)

Predictors of radiation-induced hypothyroidism in nasopharyngeal carcinoma survivors after intensity-modulated radiotherapy
por: Zhai, Ruiping, et al.
Publicado: (2022)

Clinical characteristics and prognosis of elderly nasopharyngeal carcinoma patients receiving intensity-modulated radiotherapy
por: Lyu, Yingchen, et al.
Publicado: (2020)

Clinical outcome of intensity modulated radiotherapy for carcinoma showing thymus-like differentiation
por: Kong, Fangfang, et al.
Publicado: (2016)

Induction Chemotherapy Combined With Intensity-Modulated Radiotherapy for 129 Nasopharyngeal Carcinoma Patients With Synchronous Metastases: A Retrospective Study
por: Ni, Mengshan, et al.
Publicado: (2021)

Prognostic values of hematological biomarkers in nasopharyngeal carcinoma patients treated with intensity-modulated radiotherapy
por: Ye, Lulu, et al.
Publicado: (2018)

Radiotherapy Alone Versus Concurrent or Adjuvant Chemoradiotherapy for Nasopharyngeal Carcinoma Patients with Negative Epstein–Barr Virus DNA after Induction Chemotherapy
por: Kong, Fangfang, et al.
Publicado: (2023)

Comparing Long-Term Survival and Late Toxicities of Different Sequential Chemotherapy Regimens with Intensity-Modulated Radiotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma
por: Wu, Mingyao, et al.
Publicado: (2020)

Prognostic value of nutritional markers in nasopharyngeal carcinoma patients receiving intensity-modulated radiotherapy: a propensity score matching study
por: Oei, Ronald Wihal, et al.
Publicado: (2018)

Second Primary Lung Adenocarcinoma After Intensity-Modulated Radiotherapy for Nasopharyngeal Carcinoma
por: Xue, Fen, et al.
Publicado: (2022)

Intensity-modulated radiotherapy combined with sequential cisplatin and fluorouracil chemotherapy for locoregionally advanced nasopharyngeal carcinoma
por: Wu, Mingyao, et al.
Publicado: (2018)

Local regression and control of T1‐2 nasopharyngeal carcinoma treated with intensity‐modulated radiotherapy
por: Xue, Fen, et al.
Publicado: (2018)

Long-term outcomes of nasopharyngeal carcinoma patients with T1-2 stage in intensity-modulated radiotherapy era
por: Niu, Xiaoshuang, et al.
Publicado: (2022)

Prognostic value of inflammation-based prognostic index in patients with nasopharyngeal carcinoma: a propensity score matching study
por: Oei, Ronald Wihal, et al.
Publicado: (2018)

Induction chemotherapy followed by intensity-modulated radiotherapy with reduced gross tumor volume delineation for stage T3–4 nasopharyngeal carcinoma
por: Xue, Fen, et al.
Publicado: (2017)

Long-term Patterns of Regional Failure for Nasopharyngeal Carcinoma following Intensity-Modulated Radiation Therapy
por: Xue, Fen, et al.
Publicado: (2017)

Long-term outcomes of induction chemotherapy followed by intensity-modulated radiotherapy and adjuvant chemotherapy in nasopharyngeal carcinoma patients with N3 disease
por: Niu, Xiaoshuang, et al.
Publicado: (2021)

Taxane/gemcitabine-containing chemotherapy plus locoregional IMRT for patients with de novo metastatic nasopharyngeal carcinoma: the treatment outcomes and prognostic factors analysis
por: Du, Chengrun, et al.
Publicado: (2022)

Outcome after intensity modulated radiotherapy for anaplastic thyroid carcinoma
por: He, Xiayun, et al.
Publicado: (2014)

MRI-based radiomics signature is a quantitative prognostic biomarker for nasopharyngeal carcinoma
por: Ming, Xue, et al.
Publicado: (2019)

Treatment outcomes and late toxicities of 869 patients with nasopharyngeal carcinoma treated with definitive intensity modulated radiation therapy: new insight into the value of total dose of cisplatin and radiation boost
por: Ou, Xiaomin, et al.
Publicado: (2015)

Using neoadjuvant chemotherapy and replanning intensity-modulated radiotherapy for nasopharyngeal carcinoma with intracranial invasion to protect critical normal tissue
por: Niu, Xiaoshuang, et al.
Publicado: (2013)

Radiotherapy as salvage treatment of salivary duct carcinoma in major salivary glands without radical operations
por: Di, Lu, et al.
Publicado: (2018)

Who benefited most from higher cumulative dose of cisplatin among patients with locally advanced nasopharyngeal carcinoma treated by intensity-modulated radiation therapy? A retrospective study of 527 cases
por: Ou, Xiaomin, et al.
Publicado: (2017)

Development and validation of a model for temporal lobe necrosis for nasopharyngeal carcinoma patients with intensity modulated radiation therapy
por: Wang, Jiazhou, et al.
Publicado: (2019)

Application of intensity-modulated radiotherapy in unresectable poorly differentiated thyroid carcinoma
por: Xue, Fen, et al.
Publicado: (2016)

Prognostic model for survival of local recurrent nasopharyngeal carcinoma with intensity-modulated radiotherapy
por: Tian, Y-M, et al.
Publicado: (2014)

AntiPD-L1 antibody conjugated Au-SPIOs nanoplatform for enhancing radiosensitivity and triggering anti-tumor immune response
por: Du, Chengrun, et al.
Publicado: (2022)

Treatment for retropharyngeal metastatic undifferentiated squamous cell carcinoma from an unknown primary site: results of a prospective study with irradiation to nasopharyngeal mucosa plus bilateral neck
por: Du, Chengrun, et al.
Publicado: (2017)

Impact of Paranasal Sinus Invasion on Oncologic and Dosimetric Outcomes in Nasopharyngeal Carcinoma Following Intensity-Modulated Radiation Therapy—Implications for Risk Stratification and Planning Optimization
por: Zhou, Xin, et al.
Publicado: (2020)

Salvage Intensity-Modulated Radiation Therapy (IMRT) for Locally Recurrent Nasopharyngeal Cancer after Definitive IMRT: A Novel Scenario of the Modern Era
por: Kong, Lin, et al.
Publicado: (2016)

The challenge in treating locally recurrent T3-4 nasopharyngeal carcinoma: the survival benefit and severe late toxicities of re-irradiation with intensity-modulated radiotherapy
por: Tian, Yun-Ming, et al.
Publicado: (2017)

Unraveling the patterns and pathways of local recurrence of nasopharyngeal carcinoma: evidence for individualized clinical target volume delineation
por: Ou, Xiaomin, et al.
Publicado: (2023)

The role of adjuvant chemotherapy in nasopharyngeal carcinoma with bulky neck lymph nodes in the era of IMRT
por: Xu, Tingting, et al.
Publicado: (2016)

Effectiveness and Toxicities of Intensity-Modulated Radiotherapy for Patients with Locally Recurrent Nasopharyngeal Carcinoma
por: Chen, Hai-yan, et al.
Publicado: (2013)

Patterns and prognosis of regional recurrence in nasopharyngeal carcinoma after intensity‐modulated radiotherapy
por: Xiao, Xiao‐Tang, et al.
Publicado: (2022)

Experience with combination of nimotuzumab and intensity-modulated radiotherapy in patients with locoregionally advanced nasopharyngeal carcinoma
por: Zhai, Rui-ping, et al.
Publicado: (2015)

Pretreatment prognostic factors of survival and late toxicities for patients with nasopharyngeal carcinoma treated by simultaneous integrated boost intensity-modulated radiotherapy
por: Lin, Yun-Hsuan, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_05i3gdfejnq6soh4fgrme1une0